Literature DB >> 26741253

Immunity to malaria in an era of declining malaria transmission.

Freya J I Fowkes1, Philippe Boeuf1, James G Beeson1.   

Abstract

With increasing malaria control and goals of malaria elimination, many endemic areas are transitioning from high-to-low-to-no malaria transmission. Reductions in transmission will impact on the development of naturally acquired immunity to malaria, which develops after repeated exposure to Plasmodium spp. However, it is currently unclear how declining transmission and malaria exposure will affect the development and maintenance of naturally acquired immunity. Here we review the key processes which underpin this knowledge; the amount of Plasmodium spp. exposure required to generate effective immune responses, the longevity of antibody responses and the ability to mount an effective response upon re-exposure through memory responses. Lastly we identify research priorities which will increase our understanding of how changing transmission will impact on malarial immunity.

Entities:  

Keywords:  Malaria; antibodies; falciparum; immunity; transmission; vivax

Mesh:

Year:  2016        PMID: 26741253     DOI: 10.1017/S0031182015001249

Source DB:  PubMed          Journal:  Parasitology        ISSN: 0031-1820            Impact factor:   3.234


  36 in total

Review 1.  Antimalarial drug resistance: linking Plasmodium falciparum parasite biology to the clinic.

Authors:  Benjamin Blasco; Didier Leroy; David A Fidock
Journal:  Nat Med       Date:  2017-08-04       Impact factor: 53.440

2.  Parasite load stemming from immunization route determines the duration of liver-stage immunity.

Authors:  Hardik Patel; Nouf Althubaiti; Rajesh Parmar; Naveen Yadav; Urja Joshi; Rajeev K Tyagi; Urszula Krzych; Sarat K Dalai
Journal:  Parasite Immunol       Date:  2019-04-04       Impact factor: 2.280

3.  Evaluation of 4-Amino 2-Anilinoquinazolines against Plasmodium and Other Apicomplexan Parasites In Vitro and in a P. falciparum Humanized NOD-scid IL2Rγnull Mouse Model of Malaria.

Authors:  Paul R Gilson; William Nguyen; William A Poole; Jose E Teixeira; Jennifer K Thompson; Kaiyuan Guo; Rebecca J Stewart; Trent D Ashton; Karen L White; Laura M Sanz; Francisco-Javier Gamo; Susan A Charman; Sergio Wittlin; James Duffy; Christopher J Tonkin; Wai-Hong Tham; Brendan S Crabb; Brian M Cooke; Christopher D Huston; Alan F Cowman; Brad E Sleebs
Journal:  Antimicrob Agents Chemother       Date:  2019-02-26       Impact factor: 5.191

4.  Differing rates of antibody acquisition to merozoite antigens in malaria: implications for immunity and surveillance.

Authors:  Fiona J McCallum; Kristina E M Persson; Freya J I Fowkes; Linda Reiling; Cleopatra K Mugyenyi; Jack S Richards; Julie A Simpson; Thomas N Williams; Paul R Gilson; Anthony N Hodder; Paul R Sanders; Robin F Anders; David L Narum; Chetan Chitnis; Brendan S Crabb; Kevin Marsh; James G Beeson
Journal:  J Leukoc Biol       Date:  2016-11-11       Impact factor: 4.962

5.  In Silico Prediction of Plasmodium falciparum Cytoadherence Inhibitors That Disrupt Interaction between gC1qR-DBLβ12 Complex.

Authors:  Abdul Hafiz; Rowaida Bakri; Mohammad Alsaad; Obadah M Fetni; Lojain I Alsubaihi; Hina Shamshad
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-31

6.  Declining Malaria Transmission Differentially Impacts the Maintenance of Humoral Immunity to Plasmodium falciparum in Children.

Authors:  Cleopatra K Mugyenyi; Salenna R Elliott; Xi Zen Yap; Gaoqian Feng; Philippe Boeuf; Gregory Fegan; Faith F H Osier; Freya J I Fowkes; Marion Avril; Thomas N Williams; Kevin Marsh; James G Beeson
Journal:  J Infect Dis       Date:  2017-10-17       Impact factor: 5.226

Review 7.  Anti-malarial humoral immunity: the long and short of it.

Authors:  Kai J Rogers; Rahul Vijay; Noah S Butler
Journal:  Microbes Infect       Date:  2021-03-05       Impact factor: 2.700

8.  Erythrocyte membrane proteins involved in the immune response to Plasmodium falciparum and Plasmodium vivax infection.

Authors:  Cristian Castro-Salguedo; Darío Mendez-Cuadro; Carlos Moneriz
Journal:  Parasitol Res       Date:  2021-04-02       Impact factor: 2.289

9.  Baseline Asymptomatic Malaria Infection and Immunogenicity of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein.

Authors:  Barbara E Mahon; Jakub Simon; Marc-Alain Widdowson; Mohamed Samai; Eric Rogier; Jennifer Legardy-Williams; Kenneth Liu; Jarad Schiffer; James Lange; Carolynn DeByle; Robert Pinner; Anne Schuchat; Laurence Slutsker; Susan Goldstein
Journal:  J Infect Dis       Date:  2021-12-01       Impact factor: 5.226

10.  The 2015-2016 malaria epidemic in Northern Uganda; What are the implications for malaria control interventions?

Authors:  Rodney Ogwang; Godfrey Akena; Adoke Yeka; Faith Osier; Richard Idro
Journal:  Acta Trop       Date:  2018-08-23       Impact factor: 3.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.